PR Newswire03.22.17
Endotronix Inc., a digital health medtech company providing innovative solutions for patients who suffer from advanced heart failure, announced the expansion of their management team. Recent hires include experienced medtech executives Katrin Leadley, M.D., chief medical officer (CMO), Richard Powers, chief information officer (CIO), and Mike Dilworth, vice president of manufacturing and operations, who bring a wealth of heart failure expertise as the company prepares for upcoming clinical and commercialization milestones.
The Cordella Heart Failure System consists of a cloud-based patient management system and a wireless implantable pulmonary artery (PA) sensor that enables proactive management and early detection of worsening heart failure. The data-driven system promotes ongoing therapeutic interventions to improve quality of life, reduce hospital readmissions, and lower care costs for at-home patient care. The myCordella Patient Management Platform is currently in early clinical use and first-in-human use of the Cordella PA Sensor is expected in Q3 2017.
"I am delighted to welcome Katrin, Richard, and Mike to the Endotronix team," commented Harry Rowland, CEO of Endotronix. "Their leadership and expertise will be invaluable as we advance towards our upcoming clinical milestones and commercialization of the Cordella System, which we anticipate late next year."
Dr. Katrin Leadley, a well-published author, has over 20 years of clinical and industry experience with a proven record of providing medical and scientific leadership expertise at early stage and public companies. Prior to Endotronix, Dr. Leadley held CMO roles at HeartWare (acquired by Medtronic in 2016) and JenaValve Technology as well as senior level clinical positions at Boston Scientific and Advanced Stent Technologies. As CMO, Dr. Leadley will be leading Endotronix's clinical and regulatory affairs.
Richard Powers joins the Endotronix team after an impressive tenure at CardioMEMS, culminating as chief information officer. He created their cloud-based web systems and managed the program through transition to St. Jude Medical in the 2014 acquisition. More recently, he ran a consulting business and was chief technology officer at WebOps. As CIO, Richard will be leading Endotronix's development and implementation of the myCordella Patient Management Platform.
Mike Dilworth is a seasoned manufacturing and operations executive in the healthcare industry. Most recently, Mike was Senior VP of manufacturing operations at Nanosphere (acquired by Luminex Corporation in 2016). Prior to that he held VP of manufacturing roles at Plasma Surgical, Abbott Nutrition, and Ciba Vision Corporation.
Other recent changes include: Nicolas Chronos, M.D., former Endotronix chief medical officer and practicing cardiologist, will become executive vice president of strategy and clinical affairs; Michael Nagy, former Endotronix vice president of engineering, will become chief operations officer; and following the close of Seroba Life Science's €100M fund and investment in Endotronix, Jennifer McMahon, Associate at Seroba, will join the Board of Directors.
The Cordella Heart Failure System consists of a cloud-based patient management system and a wireless implantable pulmonary artery (PA) sensor that enables proactive management and early detection of worsening heart failure. The data-driven system promotes ongoing therapeutic interventions to improve quality of life, reduce hospital readmissions, and lower care costs for at-home patient care. The myCordella Patient Management Platform is currently in early clinical use and first-in-human use of the Cordella PA Sensor is expected in Q3 2017.
"I am delighted to welcome Katrin, Richard, and Mike to the Endotronix team," commented Harry Rowland, CEO of Endotronix. "Their leadership and expertise will be invaluable as we advance towards our upcoming clinical milestones and commercialization of the Cordella System, which we anticipate late next year."
Dr. Katrin Leadley, a well-published author, has over 20 years of clinical and industry experience with a proven record of providing medical and scientific leadership expertise at early stage and public companies. Prior to Endotronix, Dr. Leadley held CMO roles at HeartWare (acquired by Medtronic in 2016) and JenaValve Technology as well as senior level clinical positions at Boston Scientific and Advanced Stent Technologies. As CMO, Dr. Leadley will be leading Endotronix's clinical and regulatory affairs.
Richard Powers joins the Endotronix team after an impressive tenure at CardioMEMS, culminating as chief information officer. He created their cloud-based web systems and managed the program through transition to St. Jude Medical in the 2014 acquisition. More recently, he ran a consulting business and was chief technology officer at WebOps. As CIO, Richard will be leading Endotronix's development and implementation of the myCordella Patient Management Platform.
Mike Dilworth is a seasoned manufacturing and operations executive in the healthcare industry. Most recently, Mike was Senior VP of manufacturing operations at Nanosphere (acquired by Luminex Corporation in 2016). Prior to that he held VP of manufacturing roles at Plasma Surgical, Abbott Nutrition, and Ciba Vision Corporation.
Other recent changes include: Nicolas Chronos, M.D., former Endotronix chief medical officer and practicing cardiologist, will become executive vice president of strategy and clinical affairs; Michael Nagy, former Endotronix vice president of engineering, will become chief operations officer; and following the close of Seroba Life Science's €100M fund and investment in Endotronix, Jennifer McMahon, Associate at Seroba, will join the Board of Directors.
